Related Experiment Video
Updated: Jul 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy]
Rafael Laredo1, Lorenzo Monserrat, Manuel Hermida-Prieto
1Servicio de Cardiología, Complejo Hospitalario Universitario Juan Canalejo e Instituto Universitario de Ciencias de la Salud de la Universidad de A Coruña, A Coruña, Spain.
Insights
Mutations in the beta-myosin heavy-chain gene (MYH7) were found in 10% of hypertrophic cardiomyopathy (HCM) families. These MYH7 mutations were more common in patients with severe hypertrophy or a family history of sudden death.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Basis of Cardiomyopathies
Background:
- Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease.
- Genetic mutations are a known cause of HCM, impacting cardiac function.
- Identifying specific gene mutations aids in understanding disease progression and inheritance patterns.
Purpose of the Study:
- To determine the frequency of mutations in the beta-myosin heavy-chain gene (MYH7) in a cohort of patients with HCM.
- To investigate the correlation between specific MYH7 genotypes and the clinical phenotypes observed in HCM patients and their families.
Main Methods:
- Single-strand conformation polymorphism analysis and gene sequencing were performed on 128 index patients with HCM.
- Phenotypes of patients with and without identified MYH7 mutations were compared.
- Phenotypic data from affected families with identified mutations were systematically recorded.
Main Results:
- Eleven MYH7 mutations were identified in 13 families (10% prevalence).
- Mutations were more frequent in patients with severe hypertrophy (>=30 mm thickness) and a family history of sudden death.
- Sudden death occurred in eight family members across four families, linked to specific MYH7 mutations like I736T.
Conclusions:
- MYH7 mutations are found in 10% of hypertrophic cardiomyopathy families, often associated with severe disease and sudden cardiac death.
- The genotype-phenotype correlation for MYH7 mutations can be variable, suggesting potential influence from other genetic or environmental factors.
- Further research is needed to identify additional genetic factors contributing to phenotypic variability in HCM.
Introduction And Objectives:
To determine the frequency of mutations in the beta-myosin heavy-chain gene (MYH7) in a cohort of patients with hypertrophic cardiomyopathy (HCM) and their families, and to investigate correlations between genotype and phenotype.
Methods:
Single-strand conformation polymorphism analysis and sequencing of fragments with abnormal MYH7 gene mobility were carried out in 128 consecutive index patients with HCM. The phenotypes of patients with and without mutations were compared and the phenotypes of identified families were recorded.
Results:
A total of 11 mutations were found in 13 families (10%); 7/11 had been previously described. The I736T mutation was found in three families and the A797T in two. One patient had two mutations (i.e., I736T and R787H). Mutations were more frequent in patients with a family history of sudden death (31%) and in those with severe hypertrophy (39% had a thickness > or = 30 mm). Mutations were found in 29 of 42 members of the 13 families, including six family members (20%) who were healthy carriers and aged < or = 36 years. Sudden death had occurred in eight members of four families: four in two families with the I736T mutation, one in a family with A797T, one in a family with R870H, and two in a family with A901P.
Conclusions:
MYH7 mutations were present in 10% of our families. Mutations were more frequent in patients with a family history of sudden death and in those with severe hypertrophy. Most mutations had been described previously. Some appeared in several families. For some mutations, the correlation between genotype and phenotype was stable, while for others, there were marked differences between the phenotypes of the index patients and their relatives, suggesting the presence of additional genetic factors that have yet to be identified.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

